November 01, 2024

Regeneron Leaders Recognized for Innovation at Eyecelerator 2024

Drs. Schleifer and Yancopoulos received the Eyecelerator Innovation Award and discussed the long and winding road to success.

Glaucoma Physician

October 23, 2024

Laser Beats Drops in Slowing Glaucoma

New data presented at a medical meeting supports a shift in the management of glaucoma from eye drops to a laser procedure, with significant benefits in reducing vision loss.

Reuters

January 01, 2024

LIVESTREAM Q + A

PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.

Contact Lens Spectrum

October 01, 2023

AAO 2023 TO MEET IN SAN FRANCISCO

PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.

Ophthalmology Management

October 07, 2024

Euretina 2024: Faricimab Shows Greater Hard Exudate Reduction Compared with Aflibercept

Faricimab’s dual inhibition mechanism led to a greater reduction in HE compared to aflibercept in DME patients.

Conexiant

August 01, 2023

EYE ON OOSS

PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.

Ophthalmology Management

October 01, 2024

Observations on the Schepens Lecture

Yasha Modi, MD, discusses the 17th Charles L. Schepens Lecture given by legendary innovator and surgeon Dr. Steve Charles during Retina Subspecialty Day at AAO 2024.

Retinal Physician

August 01, 2024

Speaking Out for Microinvasive Glaucoma Surgery

OOSS joins the ophthalmology community in presentation to Medicare carriers proposing changes to MIGS policies.

Ophthalmology Management

October 14, 2024

Euretina 2024: Voretigene Neparvovec-rzyl Therapy Long-Term Functional and Anatomical Outcomes

Patients experienced visual acuity gains in BCVA and full-field stimulus testing.

Conexiant